LPA is proud to announce two strategic partnerships that significantly expand its international footprint and policy capacity: with the International Longevity Alliance (ILA) and with Vetek — the Movement for Longevity and Quality of Life.
International Longevity Alliance (ILA)
The International Longevity Alliance is a global federation uniting more than 80 non-profit organisations across over 65 countries. Its mission is to promote healthy longevity for all people through scientific research on ageing biology, the development and safe implementation of new therapies, and the improvement of public health and research policy in the field of ageing control.
ILA acts at every level — from grassroots advocacy to national and international policy — to build a world where every person can benefit from aging amelioration and healthy longevity through innovative medical technologies. The partnership gives LPA direct access to this international network and to the policy expertise of dozens of national affiliates.
Visit longevityalliance.orgVetek — Movement for Longevity and Quality of Life
Vetek (Seniority) Association is dedicated to advancing healthy longevity for the entire population through scientific research, technological development, medical treatment, public health and educational measures, advocacy and social activism. The association places particular emphasis on ameliorating the deteriorative aging process as the central factor undermining healthy longevity.
Founded by Rafi Eitan and advised by leading Israeli and international scientists, Vetek is uniquely positioned to advance biomedical aging and longevity research in Israel and to connect that work with international policy efforts. Its decades of experience in promoting healthy ageing policies, intergenerational solidarity and longevity research are a major asset for LPA's institutional dialogue.
Visit longevityisrael.orgWhat these partnerships mean
Together, these two partnerships extend LPA's reach across the global longevity policy ecosystem — bridging European institutional dialogue with worldwide scientific advocacy and with one of the most active national longevity movements. They reinforce our conviction that healthy longevity policy is, by nature, an international undertaking.